Table 1.
Patient | Gene | Sex | Age at onset(y) | Category* | ESRD(y) | Histopathologic diagnosis | Family history** | Extra-renal symptom | Age at gene analysis(y) | eGFR (ml/min/1.73 m2) |
---|---|---|---|---|---|---|---|---|---|---|
Neph7 |
WT1 |
F | 0.33 | 2 | 0.5 | DMS | — | — | 0.75 | 5 |
Neph15 | WT1 | F | 10 | 4 | — | MGA | — | — | 16 | 114.4 |
Neph33 | WT1 | F | 3 | 4 | — | MGA | — | — | 9 | 113.5 |
Neph48 | WT1 | M | 0.5 | 4 | — | FSGS | — | micropenis, cryptorchidism | 2 | 75.82 |
Neph52 | WT1 | F | 6 | 3 | — | FSGS | — | — | 9 | 84.8 |
Neph90 | WT1 | M | 3 | 3 | 12 | FSGS | — | — | 12 | 11.9 |
Neph92 | WT1 | F | 0 | 1 | 0 | — | — | — | 0 | 14 |
Neph95 | WT1 | M | 3 | 4 | 11 | FSGS | — | — | 30 | 33.9 |
Neph107 | WT1 | F | 0.17 | 2 | 0.17 | — | — | — | 0.17 | 10.24 |
Neph132 | WT1 | F | 0.5 | 2 | 0.5 | sclerosis | — | — | 1 | 3 |
Neph136 | WT1 | F | 6 | 4 | — | MGA | — | — | 17 | 83.4 |
Neph137 | WT1 | F | 2 | 3 | — | Mesangial proliferative glomerulonephritis | — | — | 5 | 100 |
Neph154 | WT1 | M | 3 | 3 | — | FSGS | — | cryptorchidism,hypospadias | 14 | 21 |
Neph171 | WT1 | M | 9 | 3 | — | FSGS | — | — | 29 | 25.8 |
Neph185 | WT1 | M | 0.5 | 2 | 2 | DMS | — | — | 20 | 71.1 |
Neph197 | WT1 | F | 3 | 4 | 7 | FSGS | — | — | 7 | 12.5 |
Neph208 | WT1 | F | 0.42 | 2 | 0.42 | — | — | — | 0.5 | 18.76 |
Neph27 |
NPHS1 |
M | 0 | 1 | — | — | — | — | 0.08 | 34.1 |
Neph69 | NPHS1 | M | 0.08 | 1 | — | — | — | — | 0.67 | 32.1 |
Neph91 | NPHS1 | F | 8 | 3 | — | MGA | — | — | 20 | 244.3 |
Neph104 | NPHS1 | F | 0 | 1 | — | — | 1 | — | 0.08 | — |
Neph106 | NPHS1 | F | 0 | 1 | — | — | — | — | 0.17 | 55.5 |
Neph113 | NPHS1 | M | 6 | 3 | — | MGA | — | — | 32 | 165.4 |
Neph192 | NPHS1 | M | 0.75 | 3 | — | MGA | — | — | 2 | 92.3 |
Neph203 | NPHS1 | F | 7 | 3 | — | C1q nephropathy | 1 | — | 10 | 195 |
Neph59 |
INF2 |
F | 13 | 4 | — | Focal glomerular obsolescent | 2 | — | 25 | 113 |
Neph76 | INF2 | M | 10 | 4 | 25 | FSGS | 2 | — | 17 | 7.2 |
Neph134 | INF2 | M | 9 | 4 | — | FSGS | — | — | 15 | 96.6 |
Neph155 | INF2 | M | 11 | 4 | 14 | FSGS | — | Charcot-Marie-Tooth disease | 15 | 8.4 |
Neph177 | INF2 | M | 30 | 4 | — | FSGS | 2 | — | 32 | 63 |
Neph198 | INF2 | F | 13 | 4 | — | MGA | — | — | 16 | 115.2 |
Neph202 | INF2 | M | 31 | 4 | — | FSGS | 2 | — | 39 | 12.6 |
Neph227 | INF2 | M | 7 | 3 | 13 | FSGS | — | — | 22 | 53.2 |
Neph5 |
TRPC6 |
F | 3 | 4 | 6 | FSGS | — | — | 14 | 92.4 |
Neph24 | TRPC6 | F | 4 | 3 | 4 | FSGS | — | — | 4 | 91.6 |
Neph39 | TRPC6 | F | 3 | 3 | 7 | C1q nephropathy | — | — | 7 | 8.16 |
Neph139 | TRPC6 | F | 2 | 4 | — | FSGS | — | — | 2 | 94.8 |
Neph149 | TRPC6 | M | 7 | 3 | — | MGA | — | — | 8 | 95.17 |
Neph176 | TRPC6 | M | 14 | 4 | — | FSGS | 2 | — | 14 | 140.13 |
Neph234 | TRPC6 | F | 7 | 4 | — | FSGS | 2 | — | 7 | 119.8 |
Neph4 |
LAMB2 |
M | 0.33 | 2 | — | FSGS | — | — | 4 | 121 |
Neph23 | LAMB2 | F | 0 | 1 | 0.25 | Diffuse glomerular obsolescence | — | — | 1 | ESRD |
Neph58 | LAMB2 | M | 0 | 1 | 0 | — | — | microcoria | 0 | 4.1 |
Neph87 | LAMB2 | M | 0.17 | 1 | 0.5 | DMS | — | retinal detachment | 10 | 68.9 |
Neph89 | LAMB2 | M | 2 | 3 | — | sclerosis | — | — | 2 | 93.8 |
Neph133 | LAMB2 | F | 0 | 1 | 0.08 | — | — | choroiditis, chorioretinal atrophy | 6 | 89.9 |
Neph36 |
ADCK4 |
F | 6 | 4 | — | FSGS | — | — | 8 | 89.7 |
Neph56 | ADCK4 | F | 3 | 4 | — | FSGS | — | — | 4 | 111.2 |
Neph160 | ADCK4 | M | 3 | 4 | — | FSGS | — | — | 5 | 60.8 |
Neph225 | ADCK4 | F | 9 | 4 | — | FSGS | 1,2 | — | 11 | 90.9 |
Neph19 |
NUP107 |
M | 1.67 | 3 | 2.3 | FSGS | — | — | 5 | 6.2 |
Neph66 | NUP107 | F | 3 | 4 | — | — | — | — | 3 | 129.4 |
Neph147 | NUP107 | M | 7 | 4 | — | FSGS | — | — | 8 | 105.5 |
Neph68 |
LMX1B |
M | 3 | 3 | — | — | — | microcephaly | 5 | 167.61 |
Npeh77 | LMX1B | F | 3 | 3 | — | FSGS | 2 | — | 19 | 109 |
Neph37 |
ACTN4 |
M | 6 | 4 | 13 | FSGS | — | — | 12 | 66.7 |
Neph146 | ACTN4 | M | 8 | 3 | — | FSGS | — | — | 11 | 126 |
Neph129 |
PAX2 |
M | 3 | 4 | — | FSGS | 1 | — | 10 | 106.3 |
Neph230 | PAX2 | M | 8 | 4 | — | FSGS | — | — | 8 | 47.3 |
Neph178 |
COL4A5 |
F | 8 | 3 | — | FSGS | 2 | — | 54 | 20.6 |
Neph204 | COL4A5 | F | 1 | 4 | — | non—IgA nephropathy | 2 | — | 17 | 93.3 |
Neph97 |
COQ6 |
M | 0.75 | 2 | — | — | — | — | 0.92 | 83 |
Neph79 |
FAT1 |
M | 3 | 4 | — | MGA | — | — | 5 | 141.8 |
Neph189 |
PLCE1 |
M | 1 | 3 | 12 | FSGS | 1 | — | 21 | 70.16 |
Neph10 |
SMARCAL1 |
M | 7 | 3 | — | FSGS | — | — | 8 | 64.1 |
Neph143 |
TTC21B |
M | 3 | 4 | — | FSGS | — | situs inversus | 4 | 57.1 |
Neph216 |
MYH9 |
M | 3 | 4 | — | FSGS | — | — | 8 | 100.1 |
Neph224 |
CUBN |
M | 3 | 4 | — | MGA | — | — | 3 | 112 |
Neph236 |
LAMA5 |
M | 0.25 | 1 | 1 | — | 2 | — | 13 | 36.4 |
*1: Congenital nephrotic syndrome, 2: Infantile nephrotic syndrome, 3: Steroid-resistant nephrotic syndrome, 4: Focal segmental glomerular sclerosis or asymptomatic proteinuria.
**1: positive family history of proteinuria, 2: positive family history of renal failure.
Abbreviations: DMS, diffuse mesangial sclerosis; ESRD, end-stage renal disease; FSGS, focal segmental glomerular sclerosis; MGA, minor glomerular abnormality.